Sign in

Troels Lillebaek

@tlillebaek.bsky.social
318 followers 272 following 110 posts

Professor infectious Disease | focus molecular epidemiology | Global Health Section | Uni. of Copenhagen. Director | Int. Reference Lab. of Mycobacteriology | Statens Serum Institut | Copenhagen | DK. TB/NTM, Infection, transmission & control | Own views

PostsRepliesMedia
Reposted by Troels Lillebaek
European Society of Mycobacteriology @esmyco.bsky.social · 26/06/2026
📍 See you next year in Hamburg! 🇩🇪 As #ESM2026 closes, we're already looking ahead. The 47th ESM Annual Congress will take place 20-23 June 2027 at the Empire Riverside Hotel, Hamburg. Thank you all for an unforgettable week in Verona. Save the date! #ESM2027 #ESMyco
021
Reposted by Troels Lillebaek
European Society of Mycobacteriology @esmyco.bsky.social · 26/06/2026
📸 This is what #ESM2026 looked like! 214 participants from 42 countries, together in Verona for four days of science, ideas and connection. This is our community. Thank you to every one of you for making it so special. Until next time! 🧫 #ESMyco #Mycobacteriology
021
Reposted by Troels Lillebaek
European Society of Mycobacteriology @esmyco.bsky.social · 24/06/2026
More on 🔬 day 2 of #ESM2026 in Verona! great sessions: TB Short Regimens in Trials, New Diagnostic Strategies for TB & NTM, and New Diagnostics for MDR-TB. Plus Poster Session 1 and a traditional dinner to close. Thanks to all speakers & chairs! See you for Day 3 🔬 #ESMyco #Tuberculosis
011
Troels Lillebaek @tlillebaek.bsky.social · 23/06/2026
Congratulations to Bouke de Jong, winner of the Gardner Middlebrook Award at #ESM2026!
021
Reposted by Troels Lillebaek
European Society of Mycobacteriology @esmyco.bsky.social · 22/06/2026
🏅 Congratulations to Margo Diricks, winner of the Gertrud Meissner Award at #ESM2026! We're delighted to celebrate Margot's outstanding contribution to mycobacteriology, recognising the excellence and dedication she brings to our field. So well deserved 👏 #ESM2026 #ESMyco
022
Troels Lillebaek @tlillebaek.bsky.social · 22/06/2026
In one hour we will be 220 participants from 42 countries! The scientific highlight of the year for everyone interested in #mycobacteria is about to start. The 46th Annual Congress of the European Society of Mycobacteriology (ESM) will take place in Verona, Italy. #ESMyco #ESMyco2026
010
Troels Lillebaek @tlillebaek.bsky.social · 16/06/2026
Fluoroquinolone monotherapy as #tuberculosis #preventice #therapy (TPT) to contacts exposed to multidrug-resistant TB (#MDRTB). New systematic review and meta-analysisis indicates that it´s safe. The article includes a nice overview over included studies, read: journals.theunion.org/content/ijtl...
journals.theunion.org
000
Troels Lillebaek @tlillebaek.bsky.social · 01/06/2026
As President of ESM, I am very much looking forward to welcoming colleagues, collaborators, young investigators, laboratory specialists, clinicians, and researchers to Verona for what promises to be an inspiring and highly relevant meeting. Programme: www.esmycobacteriology.eu/event-progra...
esmycobacteriology.eu
Programme | ESM
000
Troels Lillebaek @tlillebaek.bsky.social · 01/06/2026
The congress also include keynote lectures, oral abstract sessions, poster pitches, poster sessions, award presentations, and excellent opportunities for networking and collaboration across the European and international mycobacteriology community.
100
Troels Lillebaek @tlillebaek.bsky.social · 01/06/2026
We prepared a very strong scientific programme covering many of the most important and rapidly evolving areas in #mycobacteriology: sex/gender, mycobacterial evolution, shorter TB treatment, new diagnostics, pathogenesis, AI, therapeutic strategies, omics-based approaches, and infection models
100
Troels Lillebaek @tlillebaek.bsky.social · 01/06/2026
The scientific highlight for everyone interested in #mycobacteria is approaching fast. The 46th Annual Congress of the European Society of Mycobacteriology (ESM) will take place in Verona, Italy, 22–25 June 2026. The detailed programme is now available online (see below) #ESMyco2026
100
Troels Lillebaek @tlillebaek.bsky.social · 26/05/2026
Medvirker i denne lille artikel om "Hvad skal du gøre, hvis du bliver smittet med #tuberkulose i forbindelse med arbejde? Og hvad er tuberkulose overhovedet? Det får du svar på i denne guide." fagbladetfoa.dk/arbejdsmiljo...
fagbladetfoa.dk
Tuberkulose som en arbejdsskade? Få svaret på det og meget mere her
Hvad skal du gøre, hvis du bliver smittet med tuberkulose i forbindelse med arbejde? Og hvad er tuberkulose overhovedet? Det får du svar på i denne guide.
010
Troels Lillebaek @tlillebaek.bsky.social · 04/05/2026
But based on mice ;-)
000
Troels Lillebaek @tlillebaek.bsky.social · 04/05/2026
Interesting article. Pretomanid remains the preferred component of the BPaL regimen but it seems delamanid could be a viable alternative if clinical reasons to substitute, including drug resistance or if pretomanid is unavailable or poorly tolerated. Read on: pubmed.ncbi.nlm.nih.gov/42053462/
pubmed.ncbi.nlm.nih.gov
Pretomanid vs delamanid in a bedaquiline-linezolid regimen: efficacy in a high-burden tuberculosis mouse model - PubMed
The bedaquiline, pretomanid, and linezolid (BPaL) regimen has shown significant efficacy in treating patients with multidrug-resistant and extensively drug-resistant tuberculosis. This study assessed ...
100
Troels Lillebaek @tlillebaek.bsky.social · 23/04/2026
Nominations are open for the Gertrud Meissner Award, for dedicated to scientists in an early phase of their career who are doing excellent research in the field of mycobacteriology. Read on: www.esmycobacteriology.eu/gertrud-meissner-award
esmycobacteriology.eu
Gertrud Meissner Award | ESM
000
Troels Lillebaek @tlillebaek.bsky.social · 23/04/2026
We have prepared a really exciting programme and it is already available on our website, se link for programme: www.esmycobacteriology.eu/event-programme
esmycobacteriology.eu
Programme | ESM
100
Troels Lillebaek @tlillebaek.bsky.social · 23/04/2026
The European Society of Mycobacteriology (ESM) annual scientific congress in Verona 2026 is approaching. Given Verona's popularity as a tourist destination, and the fact that our congress coincides with the opera festival, register and book accommodation ASAP. www.linkedin.com/posts/troels...
linkedin.com
Current meeting | ESM | Troels L.
The European Society of Mycobacteriology (ESM) annual scientific congress in Verona 2026 is approaching. Given Verona's popularity as a tourist destination, and the fact that our congress coincides wi...
100
Troels Lillebaek @tlillebaek.bsky.social · 23/04/2026
Read on: doi.org/10.1128/jcm....
doi.org
Seven decades of nontuberculous mycobacteria in Denmark: shifts in species distribution and clinical relevance | Journal of Clinical Microbiology
Infections caused by nontuberculous mycobacteria (NTM) are increasingly recognized worldwide, yet the long-term epidemiology of these human pathogens remains poorly understood. By leveraging a unique ...
000
Troels Lillebaek @tlillebaek.bsky.social · 23/04/2026
By leveraging a unique historical collection of mycobacterial isolates, this study suggests a shift in the species spectrum responsible for NTM infections in Denmark over the past seven decades
100
Troels Lillebaek @tlillebaek.bsky.social · 23/04/2026
Infections caused by nontuberculous mycobacteria (NTM) are increasingly recognized worldwide, yet the long-term epidemiology of these human pathogens remains poorly understood.
121
Troels Lillebaek @tlillebaek.bsky.social · 06/04/2026
youtu.be/38g6KvoYVoI Direkte link
youtu.be
Tuberkulose: Den mest dødelige sygdom, som vi har glemt
YouTube video by Videnskab․dk
011
Troels Lillebaek @tlillebaek.bsky.social · 06/04/2026
#tuberkulose på 10 minutter? Sygdommen hvor vi allerede har effektiv diagnostik og behandling - men tilsyneladende ikke viljen til at udrydde den fattigdom der gør, at tuberkulose fortsat er den største dræber i verden som følge af en enkelt mikroorganisme.
linkedin.com
Tuberkulose: Den mest dødelige sygdom, som vi har glemt | Troels L.
Lær om tuberkulose på 10 minutter? Sygdommen hvor vi allerede har effektiv diagnostik og behandling - men tilsyneladende ikke viljen til at udrydde den fattigdom der gør, at tuberkulose fortsat er den...
111
Troels Lillebaek @tlillebaek.bsky.social · 24/03/2026
Today, on World TB Day, marking the date when Robert Koch announced the discovery of Mycobacterium tuberculosis, the European Society of Mycobacteriology reaffirms its commitment to advancing science, research, and education in the field of mycobacteriology. Read on: www.linkedin.com/pulse/europe...
linkedin.com
010
Troels Lillebaek @tlillebaek.bsky.social · 03/03/2026
Kurset henvender sig til lægefaglige specialister, herunder (kommende) speciallæger i mikrobiologi, infektionsmedicin og lungemedicin. Kurset er gratis og foregår på Statens Serum Institut. Ved interesse for deltagelse reserver dagene og skriv til undertegnede.
010
Troels Lillebaek @tlillebaek.bsky.social · 03/03/2026
Reserver dagene: 23-25 november 2026 afholder Afdeling for Tuberkulose og Mykobakterier på SSI intensivt kursus i mykobakteriologi (tuberkulose og non-tuberkuløse mykobakterier). Emnerne er diagnostik, klinik, behandling, kontrol og forskning.
100
Troels Lillebaek @tlillebaek.bsky.social · 03/03/2026
www.linkedin.com/posts/troels...
linkedin.com
Reserver dagene: 23-25 november 2026 afholder Afdeling for Tuberkulose og Mykobakterier på SSI intensivt kursus i mykobakteriologi (tuberkulose og non-tuberkuløse mykobakterier). Emnerne er… | Troels ...
Reserver dagene: 23-25 november 2026 afholder Afdeling for Tuberkulose og Mykobakterier på SSI intensivt kursus i mykobakteriologi (tuberkulose og non-tuberkuløse mykobakterier). Emnerne er diagnostik...
111
Troels Lillebaek @tlillebaek.bsky.social · 16/02/2026
#Tuberculosis (TB) among #refugee #minors in low-incidence countries? In this article we estimated the incidence of TB disease among refugee minors compared to Danish-born. There is a need for national policies and clinical guidelines, read: pubmed.ncbi.nlm.nih.gov/41689350/
pubmed.ncbi.nlm.nih.gov
High Tuberculosis Incidence Among Refugee Minors in Denmark: A Register-Based Cohort Study - PubMed
Our findings underscore the need for national policies and clinical guidelines for TB screening of all refugee minors upon arrival to reduce morbidity and advance TB elimination efforts.
043
Troels Lillebaek @tlillebaek.bsky.social · 16/02/2026
Fremskrivning af TB tilfælde i Danmark, se detaljer i artiklen
010
Troels Lillebaek @tlillebaek.bsky.social · 16/02/2026
ugeskriftet.dk/videnskab/el...
ugeskriftet.dk
Eliminering af tuberkulose i Danmark
110
Troels Lillebaek @tlillebaek.bsky.social · 16/02/2026
#Eliminering af #tuberkulose i #Danmark ? I ny statusartikel i Ugeskrift for Læger sætter Isik Somuncu Johansen, Pernille Ravn, Andreas Fløe, Anders Koch, Christian Wejse & undertegnede fokus på, hvor Danmark står i forhold til WHO’s mål om tuberkulose-elimination. www.linkedin.com/posts/troels...
linkedin.com
Eliminering af tuberkulose i Danmark | Troels L.
Ny statusartikel i Ugeskrift for Læger: #Eliminering af #tuberkulose i #Danmark ? I en netop publiceret statusartikel i Ugeskrift for Læger sætter Isik Somuncu Johansen, Pernille Ravn, Andreas Fløe, A...
121
Troels Lillebaek @tlillebaek.bsky.social · 12/02/2026
#Tuberkulose og #ulighed er tæt forbundet: Jeg kan varmt anbefale en ny statusartikel om social ulighed i sundhed skrevet af Finn Diderichsen i Ugeskrift for Læger. Se min anbefaling på LinkedIn www.linkedin.com/posts/troels...
linkedin.com
Ulighedens grammatik | Troels L.
#Tuberkulose og #ulighed er tæt forbundet: Jeg kan varmt anbefale denne nye statusartikel om social ulighed i sundhed skrevet af Finn Diderichsen i Ugeskrift for Læger. Artiklen giver et præcist beg...
111
Troels Lillebaek @tlillebaek.bsky.social · 22/12/2025
The chapter address diagnostic principles, incl. epidemiology, disease concepts, when to suspect NTM, and clinical presentations, followed by microbiological methods, incl mic, cult, and mol techniques. It´s intended for labs diagnosing mycobacteria, based on authors’ experience / cited literature
020
Troels Lillebaek @tlillebaek.bsky.social · 22/12/2025
ECDC just updated "Handbook on tuberculosis #laboratory #diagnostic methods in EU". The update includes a new chapter on “The diagnosis of #nontuberculous #mycobacteria (NTM)”, recognising these increasing and difficult-to-treat mycobacteria. Read on in capter 11 from page 126:
ecdc.europa.eu
110
Troels Lillebaek @tlillebaek.bsky.social · 03/07/2025
Thanks to all participants for a fantastic meeting with focus on all aspects of #mycobacteriology at #ESMyco2025
010
Reposted by Troels Lillebaek
Conor (Conchúr) Meehan @conmeehan.bsky.social · 23/06/2025
Great presentation from Xenia at #esm2025 supported by @micronorman.bsky.social and @tlillebaek.bsky.social and others on decades of NTM isolates from patients and how it changes over those years.
083
Reposted by Troels Lillebaek
European Society of Mycobacteriology @esmyco.bsky.social · 22/06/2025
A huge congratulations to @jodyphelan.bsky.social from @lshtm.bsky.social l for receiving the Gertrud Meissner Award at #ESM2025! 🏆 His work on bioinformatic pipelines to predict drug resistance is truly impactful. Well deserved! 🎉 #Tuberculosis #Awards #Science
052
Reposted by Troels Lillebaek
European Society of Mycobacteriology @esmyco.bsky.social · 22/06/2025
The prestigious Gardner Middlebrook Award is presented to Brigitte Gicquel from @pasteur.fr at #ESM2025. 🏆 Congratulations on this incredible honor, recognizing your immense contributions to our understanding of TB genetics and virulence. 👏 #Mycobacteriology
051
Troels Lillebaek @tlillebaek.bsky.social · 18/06/2025
How to #treat #TB patients with #expanded #resistance to one or more of bedaquiline, linezolid, a third-generation fluoroquinolone, a nitroimidazole (pretomanid or delamanid, and/or clofazimine? Clinical experts elaborates best clinical practices, read on: pmc.ncbi.nlm.nih.gov/articles/PMC...
pmc.ncbi.nlm.nih.gov
Clinical best practices for caring for people with expanded resistance to newer TB drugs
Strains of Mycobacterium tuberculosis with resistance to the new and repurposed drugs included in the all-oral shorter TB regimens recommended by WHO for the treatment of multidrug-resistant/rifampici...
010
Troels Lillebaek @tlillebaek.bsky.social · 15/05/2025
It´s onsite, 09 - 11 September 2025 Vilnius, Lithuania.
000
Troels Lillebaek @tlillebaek.bsky.social · 15/05/2025
Program www.escmid-foundation.org/fileadmin/es...
escmid-foundation.org
000
Troels Lillebaek @tlillebaek.bsky.social · 15/05/2025
Join course "Optimising Management of TB and Mycobacterial Infections with Genomic Approaches". For mycobacteriology experts and young clinicians. Ideally, candidate trainees should be involved in implementation of NGS technologies for clinical management of TB & other mycobacterial diseases / NTM
escmid-foundation.org
Optimising Management of Tuberculosis and Mycobacterial Infections with Genomic Approaches
200
Troels Lillebaek @tlillebaek.bsky.social · 07/05/2025
New review study from colleagues, On the way to #tuberculosis #elimination, expanded #contact #tracing including additional subgroups may play a role. Perhaps first, let us make sure contact tracing is performed systematically in already recommended groups/populations? doi.org/10.5588/pha....
doi.org
TB yields from expanded contact tracing investigations: Ingenta ConnectBACKGROUNDMETHODSRESULTSCONCLUSION
000
Troels Lillebaek @tlillebaek.bsky.social · 03/05/2025
www.esmycobacteriology.eu/event-home
esmycobacteriology.eu
Current meeting | ESM
001
Troels Lillebaek @tlillebaek.bsky.social · 03/05/2025
Last chance to submit your abstract Monday. Join us at European Society of Mycobacteriology annual congress in Lisbon, Portugal 🔬 #ESMyco
100
Troels Lillebaek @tlillebaek.bsky.social · 07/04/2025
Also in DK, we need strong support networks and health systems that reach the vulnerable groups where they are. Let’s not wait for the numbers to rise like in UK but but focus on targeted prevention to stay ahead of the curve.
010
Troels Lillebaek @tlillebaek.bsky.social · 07/04/2025
TB continues to disproportionately affect the most vulnerable. E.g. people experiencing homelessness, migration and socio-economic instability. They are at higher risk of infection and face barriers that complicate access to diagnosis and completion of treatment.
110
Troels Lillebaek @tlillebaek.bsky.social · 07/04/2025
The BMJ editorial underscores the need for pronged action, stronger healthcare support, and targeted interventions, especially for vulnerable groups. In Denmark, we don´t see the same general increase in TB incidence. However, we see similar patterns within specific high-risk groups
100
Troels Lillebaek @tlillebaek.bsky.social · 07/04/2025
Things can change fast. In UK, after > a decade of declining incidence, TB is once again on the rise. In 2024, 5,480 people fell ill with TB in England, an increase of 13% from 2023, marking the highest rise since 1970 and continuing a worrying trend from 2021​.
doi.org
111
Reposted by Troels Lillebaek
Tom Scriba @tomscriba.bsky.social · 28/03/2025
Facts and myths about measles - The Lancet Infectious Diseases www.thelancet.com/journals/lan...
thelancet.com
Facts and myths about measles
It seems ironic that Robert F Kennedy Jr, one of the most prominent antivaccine activists, has been made Secretary of Health and Human Services in the USA while one of the largest recent measles outbr...
033
Reposted by Troels Lillebaek
European Society of Mycobacteriology @esmyco.bsky.social · 24/03/2025
It's World Tuberculosis Day,let's unite to stop TB in its tracks! 🚫🦠 Join us at the vibrant 45th Annual Congress of the European Society of Mycobacteriology in Lisbon (22-25 June 2025). Save the date, register today! 🎯 www.esmycobacteriology.eu/event-home #EndTB
033